Invention Grant
- Patent Title: Therapeutic compositions for treatment of human immunodeficiency virus
-
Application No.: US17738803Application Date: 2022-05-06
-
Publication No.: US11744802B2Publication Date: 2023-09-05
- Inventor: Benjamin Micah Collman , Lei Hong , Joanna M. Koziara
- Applicant: Gilead Sciences, Inc.
- Applicant Address: US CA Foster City
- Assignee: Gilead Sciences, Inc.
- Current Assignee: Gilead Sciences, Inc.
- Current Assignee Address: US CA Foster City
- Main IPC: A61K31/5365
- IPC: A61K31/5365 ; A61K9/24 ; A61K9/20 ; A61K31/513 ; A61K31/675 ; A61K31/553 ; A61P31/18 ; A61K9/28 ; A61K31/537 ; A61K9/00
Abstract:
A solid oral dosage form is provided, comprising a compound of Formula I or a pharmaceutically acceptable salt thereof, tenofovir alafenamide or a pharmaceutically acceptable salt thereof, and emtricitabine or a pharmaceutically acceptable salt thereof.
Public/Granted literature
- US20220378798A1 THERAPEUTIC COMPOSITIONS FOR TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS Public/Granted day:2022-12-01
Information query
